FOSL1 and posterior cortical atrophy: In summary, the collective data illustrate that FOSL1 plays as a pioneer factor or a master regulator to control the PCSC transcriptional program, and it will be fascinating to see the clinical outcomes of the AP1 inhibitor in PCa management.